XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Ethereum Consolidates Below $2.7K as $2.4K Downside Looms
Ethereum is consolidating below $2,700 after running into fresh resistance at that level, with price action now pointing toward $2,400 as the key downside level...
Strategy Buys 1,665 BTC in Second Weekly Purchase
Strategy has purchased an additional 1,665 BTC, marking the company’s second consecutive weekly Bitcoin acquisition and bringing its disclosed total holdings to...
Citi Partners With Coinbase on Stablecoin Payments for Institutions
Citigroup is partnering with Coinbase to offer stablecoin payment services aimed at institutional clients, according to reports.
Analyst Alleges $18.4M Extracted in 53 Robinhood Chain Launches
An analyst has alleged that $18. 4 million was extracted across 53 token launches on Robinhood Chain, according to a report by CryptoPotato.
Evernorth Nears Shareholder Vote on Nasdaq Plans
Evernorth, the XRP-focused treasury firm pursuing a Nasdaq listing, is approaching a shareholder vote connected to those plans. The vote represents a crucial mi...
Leveraged Funds Turn Net-Short in CME Bitcoin Futures
Leveraged funds added a net 1,599 short contracts in CME Bitcoin futures in the week through Sept. 22, according to the latest Commitments of Traders report pub...
